Elutia(ELUT) - 2024 Q2 - Quarterly Results

Exhibit 99.1 Elutia Announces Second Quarter 2024 Results Launch Production of EluPro Underway, Commercial Team Expansion Continues, Financial Position Solidified SILVER SPRING, Md., August 7, 2024 — Elutia Inc. (Nasdaq: ELUT) ("Elutia" or the "Company"), a pioneer in drug-eluting biomatrix products, today provided a business update and financial results for the second quarter ended June 30, 2024. Business Highlights: · Received FDA clearance for EluPro, the first antibiotic-eluting BioEnvelope for protecti ...